$Suppl Fig 2 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma$

Suppl Fig 2 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma

<p>Supplemental Figure 2. MEDI-570 effects on lymphocyte and leukocyte populations. Baseline-normalized, absolute counts (ABS) of circulating cell populations were plotted on study days 1, 7, 14 and 21 from patients enrolled in each dose group as indicated. A) Total CD3+CD8+ cytotoxic T cells...

Бүрэн тодорхойлолт

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Julio C. Chavez (15181310) (author)
Бусад зохиолчид:	Francine M. Foss (15181313) (author), Basem M. William (15181316) (author), Jonathan E. Brammer (15181319) (author), Sonali M. Smith (15181322) (author), Anca Prica (15181325) (author), Jasmine M. Zain (15181328) (author), Joseph M. Tuscano (15181331) (author), Harsh Shah (15181334) (author), Neha Mehta-Shah (15028830) (author), Praveen Ramakrishnan Geethakumari (15181337) (author), Ben X. Wang (15181340) (author), Stephanie Zantinge (15181343) (author), Lisa Wang (15181346) (author), Ling Zhang (15055348) (author), Anmarie Boutrin (15181349) (author), Weiguang Zhao (15181352) (author), Lily Cheng (15181355) (author), Nathan Standifer (15055246) (author), Lisa Hewitt (15181358) (author), Enowmpey Enowtambong (15181361) (author), Weiping Shao (15181364) (author), Shringi Sharma (15181367) (author), Gianluca Carlesso (15131121) (author), Jeffrey A. Moscow (15056798) (author), Lillian L. Siu (14851075) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase I clinical trials Hematological Cancers Lymphomas Immunotherapy Antibody immunotherapy
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Хамгийн түрүүнд сэтгэгдэл үлдээх!

Suppl Fig 2 from Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma

Ижил төстэй зүйлс